Tao Huang

Sep 23, 2024 | mdpi.com | Tao Huang |Xiaolong Alan Zhou |Ke He |Meina Fei

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Aug 12, 2024 | jamanetwork.com | Tao Huang |Alessandro Bosi |Morgan E. Grams

Key PointsQuestion  Is the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) vs dipeptidyl peptidase-4 inhibitors (DPP-4is) associated with different rates of hyperkalemia or prolonged renin-angiotensin system (RAS) inhibitor use in people with type 2 diabetes (T2D)? Findings  In this cohort study of 33 280 patients with T2D, the use of GLP-1RAs was associated with a lower rate of hyperkalemia and prolonged RAS inhibitor use compared with the use of DPP-4is.

Aug 5, 2024 | chemistryviews.org | Vera Koester |Tao Huang

Manganese complexes are promising photocatalysts due to their eco-compatibility, versatile valence states, and multiple electronic excitation capabilities, though limited by poor visible light response and short excited-state lifetimes. Yu-Mei Lin, Xiamen University, China, and colleagues have developed manganese complexes with boron-containing N-heterocyclic carbene (NHC) ligands.

Jul 18, 2024 | arxiv.org | Tao Huang |Chang Xu

Jul 9, 2024 | scijournals.onlinelibrary.wiley.com | Li Zhang |Qiqi Zhang |Tao Huang |Hui Jiang

DATA AVAILABILITY STATEMENT The data that support the findings of this study are available from the corresponding author upon reasonable request.